Fundraising Fox

Pear VC2023 Investments

5 investments dated 2023 · listed companies and verified rows first · show all

Blue Labsbluelabs.krSep 2023 · $25M

BlueLabs produces water purification filters and eco-friendly water treatment materials from recycled oyster shells, addressing water contamination and circular economy challenges.

Circular EconomyCleantechClimate TechImpact & Social GoodWellness & FitnessSeocho, KR

정상호 (Sang-ho Jung)

Co-investorsTechstarsBasis Set VenturesCaffeinated CapitalDay One VenturesHustle FundKleiner Perkins+1 more

Honey Homeshoneyhomes.cominJun 2023 · $9M

Honey Homes pairs households with dedicated, vetted handymen to manage home maintenance and upgrades through a technology platform.

B2B MarketplacesConsumerPropTechSaaSOakland, US

Vishwas PrabhakaraAvantika PrabhakaraVanti Prabhakara

Co-investorsAngel Collective Opportunity FundEra VenturesFlybridge Capital PartnersGaruda VenturesKhosla VenturesRecall Capital+2 more

Orby AIorby.aiin𝕏May 2023acquired by Uniphore

Orby AI was acquired by Uniphore to contribute Large Action Models, neuro-symbolic reasoning, and agentic process discovery capabilities to Uniphore's Business AI Cloud platform.

AI & Machine LearningDeveloper ToolsEnterprise SoftwareMountain View, US

Na Liu(Executive Officer, Director)Dongxu Lu(Executive Officer, Director)Bella Liu(Founder)inUmesh Sachdev(CEO & Co-founder of Uniphore)

Co-investorsNew Enterprise Associates (NEA)Wing

Polimorphicpolimorphic.cominNov 2023 · $5.6M

Polimorphic offers an AI platform for government service operations, handling resident requests from intake to resolution across departments and systems.

AI & Machine LearningGovTechSaaSNew York, US

Parth Shah(Executive Officer, Director)Daniel Smith(Executive Officer, Director)

BoardEthan Daly(Director)inLatif Peracha(Director)inMo Koyfman(Director)in

Co-investorsAnorak VenturesShine CapitalGeneral CatalystM13

Range Biotechnologiesrange.bioinJun 2023 · $5.2M

Range Bio (Range Biotechnologies) develops next-generation diagnostics using translational proteomics for applications in human health.

BiotechHealthtechMedical Devices

Brandon Wilson, Ph.D.(Co-founder & CEO)Brandon Wilson(Co-founder & CEO)

Co-investorsArtis VenturesCivilization Ventures Management, LlcFifty YearsHAWKTAILPage One VenturesPillar

Rows marked “SEC filing” are inferred from directors named on the company's SEC Form D — public regulatory data, not a portfolio list published by the firm.